Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Antifungal activity of magnolol and honokiol

Abstract

Two neolignan compounds, magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl,1) and honokiol (5,5′-diallyl-2,4′-dihydroxybiphenyl,2), were isolated from the stem bark ofMagnolia obovata and evaluated for antifungal activity against various human pathogenic fungi. Compound1 and2 showed significant inhibitory activities againstTrichophyton mentagrophytes, Microsporium gypseum, Epidermophyton floccosum, Aspergillus niger, Cryptococcus neoformans, andCandida albicans with minimum inhibitory concentrations (MIC) in a range of 25–100 μg/ml. Therefore, compound1 and2 could be used as lead compounds for the development of novel antifungal agents.

This is a preview of subscription content, log in to check access.

References

  1. Bae, K., Yoo, B., Lee, M. and Seo, W., Antimicrobial activities of hydroxybiphenyl derivatives (I), Antibacterial activities and HPLC determination of magnolol and honokiol.Arch. Pharm. Res., 8, 85–89 (1985).

  2. Chang, B. S., Lee, Y. M., Ku, Y., Bae, K. H. and Chung, C. P., Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms.Planta Medica, 64, 367–369 (1998).

  3. Fukuyama, Y., Otoshi, Y., Miyoshi, K., Hasegawa, N., Kan, Y. and Komada, M., Structure of magnolianin, A novel triligna possessing potent 5-lipoxygenase inhibitory activity.Tetrahedron Lett., 34, 1051–1054 (1993).

  4. Grayer, R. J. and Harbone, J. B. A., Survey of antifungal compounds from higher plants.Phytochemistry, 37, 19–42 (1994).

  5. Huang, K. C.,The Pharmacology of Chinese Herb’s. CRE Press, Ann Arbor, p. 173, 1993.

  6. Kijjoa, A., Pinto, M. M. M., Tantisewie, B. and Herz, W., A biphenyl type neolignan and biphenyl ether fromMagnolia henryi.Phytochemistry, 28, 1284–1286 (1989).

  7. Kwon, B. M., Kim, M. K., Lee, S. H., Kim, J. A., Lee, I. L., Kim, Y. K. and Bok, S. H., Acyl-CoA: Cholesterol acyltransferase inhibitors fromMagnolia obovata.Planta Medica, 63, 550–551 (1997).

  8. Mattew, P. S., Omar, P. S. and Jerome, L. S., Systemic drugs in the treatment of dermatophytosis.Int. J. Dermatology, 32, 16–20 (1993).

  9. Moore, G. S. and Jaciow, D. W.,Mycology for the clinical laboratory. Reston Publishing, Virginia, pp. 262–266 (1979).

  10. Namba, T., Tsunezuka, M., Bae, K. H. and Hattori, M., Studies on dental caries prevention by traditional Chinese medicines (part I), Screening of crude drugs for antibacterial action againstStreptococcus mutans.Shoyaku Zasshi, 35, 295–302 (1981).

  11. Namba, T., Tsunezuka, M. and Hattori, M., Dental caries by traditional Chinese medicines (part II), Potent antibacterial action of Magnoliae Cortex extracts againstStreptococcus mutans.Planta Medica, 44, 100–106 (1982).

  12. Nitao, J. K., Nair, M. G., Thorogood, D. L., Johnson, K. S. and Scriber, J. M., Bioactive neolignans from the leaves ofMagnolia virginiana.Phytochemistry, 30, 2193–2195 (1991).

  13. Ormsby, O. S. and Montgomery, M.,Disease of the skin. Lea & Fibiger, Philadelphia, p. 1128, 1954.

  14. Seo, W. J., Koo, S. H. and Bae, K. H., Antimicrobial activity of hydroxybiphenyl derivatives.Arch. Pharm. Res., 9, 127–130 (1986).

  15. Yahara, S., Nishiyori, T., Kohda, A., Nohara, T. and Nishioka I., Isolation and characterization of phenolic compounds from Magnoliae Cortex produced in China.Chem. Pharm. Bull., 39, 2024–2036 (1991).

  16. Yamaguchi, H., Antifungal agents-recent trends in development and progress in research of action mechanism.Jap. J. Clinic. Med., 49, 2176–2185 (1990).

Download references

Author information

Correspondence to Ki Hwan Bae.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bang, K.H., Kim, Y.K., Min, B.S. et al. Antifungal activity of magnolol and honokiol. Arch Pharm Res 23, 46–49 (2000). https://doi.org/10.1007/BF02976465

Download citation

Key words

  • Magnolol
  • Honokiol
  • Human pathogenic fungi
  • Magnolia obovata
  • Magnoliaceae